Skip to main content
. Author manuscript; available in PMC: 2016 Sep 1.
Published in final edited form as: Lancet Oncol. 2015 Jul 30;16(9):1025–1036. doi: 10.1016/S1470-2045(15)00201-6

Figure 2.

Figure 2

Figure 2

Forest plot of overall survival in subgroups of patients treated with vosaroxin or placebo in combination with cytarabine.

The vertical dashed line indicates the hazard ratio in the overall population. CI= confidence interval; ITT=intention-to-treat.